Digoxin
- Product NDC
- 51655-403
- 11-digit product format
- 516550403
- Labeler code
- 51655
- Product ID
- 51655-403_48fee81d-40f1-bacd-e063-6394a90a1342
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Digoxin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Northwind Health Company, LLC
- Application
- ANDA215307
- Marketing category
- ANDA
- Marketing start
- 2023-04-13
- Substance
- DIGOXIN
- Active strength
- .125 mg/1
- Pharmacologic classes
- Cardiac Glycoside [EPC], Cardiac Glycosides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Digoxin
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DIGOXIN | .125 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 73K4184T59 |
| Rxcui | 197604 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51655-403-52 | Digoxin | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51655-403 | DIGOXIN TABLET [NORTHWIND PHARMACEUTICALS, LLC] | 1 | Current NDC, 1 package rows | 20230420_f9897bec-c16f-2728-e053-6394a90aecb7.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 51655-403-52 | 51655040352 | 30 TABLET in 1 BOTTLE, PLASTIC (51655-403-52) | 30 tablet | 2023-04-13 | No | No | Current |